Sun Pharma Advanced Research Company Ltd vs Vivanza Biosciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 11, 2026

Key Highlights

The Latest Trading Price of Sun Pharma Advanced Research Company Ltd is ₹ 171.95 as of 11 May 11:40 . The P/E Ratio of Sun Pharma Advanced Research Company Ltd changed from -14 on March 2025 to -14 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Vivanza Biosciences Ltd changed from 687.4 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Sun Pharma Advanced Research Company Ltd changed from ₹ 5823 crore on March 2023 to ₹ 4802 crore on March 2025 . This represents a CAGR of -6.22% over 3 yearsThe Market Cap of Vivanza Biosciences Ltd changed from ₹ 52.24 crore on March 2021 to ₹ 7.96 crore on March 2025 . This represents a CAGR of -31.36% over 5 years The revenue of Sun Pharma Advanced Research Company Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 8.45 crore. This represent the decline of -100% The revenue of Vivanza Biosciences Ltd for the Mar '26 is ₹ 6.37 crore as compare to the Dec '25 revenue of ₹ 45.33 crore. This represent the decline of -85.95% The ebitda of Sun Pharma Advanced Research Company Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ -69 crore. This represent the decline of -100% The ebitda of Vivanza Biosciences Ltd for the Mar '26 is ₹ -0.22 crore as compare to the Dec '25 ebitda of ₹ 0.29 crore. This represent the decline of -175% The net profit of Sun Pharma Advanced Research Company Ltd changed from ₹ -95.9 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Vivanza Biosciences Ltd changed from ₹ 0.27 crore to ₹ -0.45 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Sun Pharma Advanced Research Company Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vivanza Biosciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Limited (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems.
The Company works on innovation and new product development for global markets.
They undertake projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS). Sun Pharmaceutical Advanced Research Company Limited was incorporated on March 1, 2006 as an innovative and development company.
It commenced operations on March 22, 2006.
As per Scheme of Arrangement, the entire business undertaking of the Innovative Research & Development including Novel Drug Delivery System (NDDS) Division of Sun Pharmaceuticals Industries' Research & Development Undertaking was transferred and vested into the Company effective from February 28, 2007.

About Vivanza Biosciences Ltd

Vivanza Biosciences Limited, formerly known as Ivee Injectaa Limited was established in March, 1982 as a Private Limited Company and was converted into a Public Limited Company in May, 1992.
Due to recessionary trends which lead to difficult business conditions in year 1999-2000, the parenteral industry suffered a setback and due to this, the name of the Company was changed from Ivee Injectaa Limited to Vivanza Biosciences Limited in 2015. The Company is focused in commercializing novel and generic pharmaceuticals, offering patients better, safe and more accessible medicines.
It is presently engaged in the business of Pharmaceutical Products. Head quartered in Gujarat, India, Company came into existence in April 2016 to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system.

FAQs for the comparison of Sun Pharma Advanced Research Company Ltd and Vivanza Biosciences Ltd

Which company has a larger market capitalization, Sun Pharma Advanced Research Company Ltd or Vivanza Biosciences Ltd?

Market cap of Sun Pharma Advanced Research Company Ltd is 5,609 Cr while Market cap of Vivanza Biosciences Ltd is 7 Cr

What are the key factors driving the stock performance of Sun Pharma Advanced Research Company Ltd and Vivanza Biosciences Ltd?

The stock performance of Sun Pharma Advanced Research Company Ltd and Vivanza Biosciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sun Pharma Advanced Research Company Ltd and Vivanza Biosciences Ltd?

As of May 11, 2026, the Sun Pharma Advanced Research Company Ltd stock price is INR ₹172.85. On the other hand, Vivanza Biosciences Ltd stock price is INR ₹1.9.

How do dividend payouts of Sun Pharma Advanced Research Company Ltd and Vivanza Biosciences Ltd compare?

To compare the dividend payouts of Sun Pharma Advanced Research Company Ltd and Vivanza Biosciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.